HOME
PRODUCTS
Drug Testing
Cardiovascular Diseases
Infectious Diseases
Cerebrovascular Diseases
Thromboembolic Diseases
TRIAGE SYSTEM
CARDIAC PANEL
BNP TEST
CARDIOPROFILER PANEL
PROFILER SHORTNESS OF BREATH PANEL
D-DIMER TEST
NGAL TEST
TOX DRUG SCREEN
DRUGS OF ABUSE PANEL
PARASITE PANEL
REIMBURSEMENT
Biosite Inc.

Better outcomes begin with better diagnosis

Diagnosis is the critical link in medicine today. Timely, accurate diagnosis can mean the difference between relief of symptoms and prolonged suffering, between early intervention and missed therapeutic opportunities, and, in the gravest instances, between life and death.

Finding better and faster ways to achieve accurate diagnosis can potentially improve patient management, lead to earlier therapeutic intervention and reduce the costs associated with indecision, benefiting both patients and healthcare providers.

Better diagnosis begins with Biosite®

Striving for sustained growth, Biosite has adopted a strategy that encompasses the diagnostic continuum from protein validation to patient care. Through combined expertise in diagnostic discovery and commercialization, Biosite is focused on developing novel diagnostics tests that are capable of immediately and accurately diagnosing and assessing critical conditions, which can take several hours or even days using conventional testing methods.

For years, Biosite customers around the globe have validated our approach to the science of diagnosis, and as a result, a company that once seemed radically at odds with the diagnostic industry’s norms is now a fixture in health care settings of every imaginable size and type. Today, in fact, Biosite technology is used in physician's office laboratories, more than 50% of all U.S. hospitals and in approximately 40 other countries by clinicians who share our belief that a better, more rapid diagnosis can lead to better outcomes.